Erythropoietin gone expression is suppressed after lipopolysaccharide or interleukin-1β injections in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 273, Issue 3 42-3, 1997, Pages

  Frede, Stilla ^a   Fandrey, Joachim ^b   Pagel, Horst ^b   Hellwig, Thomas ^b   Jelkmann, Wolfgang ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Hypoxia; Kidney; Tumor necrosis factor

Indexed keywords

ERYTHROPOIETIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATORY DISEASE; INSPIRATORY CAPACITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ANOXIA; BIOSYNTHESIS; BLOOD; DRUG EFFECT; ESCHERICHIA COLI; GENETIC TRANSCRIPTION; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY CIRCULATION; KINETICS; MALE; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE;

ANIMALS; ANOXIA; DNA PRIMERS; ERYTHROPOIETIN; ESCHERICHIA COLI; GLOMERULAR FILTRATION RATE; INTERLEUKIN-1; KIDNEY; KINETICS; LIPOPOLYSACCHARIDES; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE;

EID: 0031227765     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.273.3.r1067     Document Type: Article

References (18)

1. Arai, K., F. Lee, A. Miyajima, S. Miyatake, N. Arai, and T. Yokota. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59: 783-836, 1990.
2. Baer, A. N., E. N. Dessypris, E. Goldwasser, and S. B. Krantz. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br. J. Haematol. 66: 559-564, 1987.
3. Beutler, B., and V. Kruys. Lipopolysaceharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself. J. Cardiovasc. Pharmacol. 25, Suppl. 2: S1-S8, 1995.
4. Camacho, J., F. Arnalich, A. F. Zamorano, and J. J. Vazquez. Serum erythropoietin levels in the anaemia of chronic disorders. J. Intern. Med. 229: 49-54, 1991.
5. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
6. Fandrey, J., and H. F. Bunn. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood 81: 617-623, 1993.
7. Faquin, W. C., T. J. Schneider, and M. A. Goldberg. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79: 1987-1994, 1992.
8. Frede, S., J. Fandrey, and W. Jelkmann. Interleukin 1β and phorbol ester induce tumour necrosis factor α production in a hepatic cell line (HepG2). Pflügers Arch. 431: 923-927, 1996.
9. Giroir, B. P., J. H. Johnson, T. Brown, G. L. Allen, and B. Beutler. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90: 693, 1992.
10. Gough, S. R., M. D. Mosher, and K. P. Conrad. Metabolism of erythropoietin in conscious pregnant rats. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R1117-R1120, 1995.
11. Hochberg, M. C., C. M. Arnold, B. B. Hogans, and J. L. Spivak. Serum immunoreactive erythropoietin in rheumatoid arthritis; impaired response to anemia. Arthritis Rheum. 31: 1318-1321, 1988.
12. Jelkmann, W. Erythropoietin: structure, control of production, and function. Physiol. Rev. 72: 449-489, 1992.
13. Jelkmann, W., H. Pagel, M. Wolff, and J. Fandrey. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci. 50: 301-308, 1992.
14. Jelkmann, W., M. Wolff, and J. Fandrey. Modulation of the production of erythropoietin by cytokines: in vitro studies and their clinical implications. Contrib. Nephrol. 87: 68-77, 1990.
15. Loppnow, H., F. Stelter, U. Schönbeck, C. Schlüter, M. Ernst, C. Schütt, and H.-D. Flad. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect. Immun. 63: 1020-1026, 1995.
16. Lukens, J. N. Control of erythropoiesis in rats with adjuvant-induced chronic inflammation. Blood 41: 37-44, 1973.
17. Means, R. T., and S. B. Krantz. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80: 1639-1647, 1992.
18. Miller, C. B., R. J. Jones, S. Piantadosi, M. D. Abeloff, and J. L. Spivak. Decreased erythropoietin response in patients with the anemia of cancer. N. Engl. J. Med. 322: 1689-1692, 1990.